Long-term monitoring of leukocyturia and bacteriuria after acute obstructive pyelonephritis


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The generally accepted standard of antibiotic therapy aimed at causative agent does not exclude the risk of acute obstructive pyelonephritis (AOP) to become chronic after the end of antibiotic therapy, resulting in a high incidence of relapses. To assess the outcomes of the AOP, we undertook a prospective clinical trial. Materials and methods. The study comprised 51 consistently selected patients (12 men and 39 women) with AOP occurred as a result of unilateral ureteric calculus obstruction. Inclusion criteria for the study were as follows: no history of urological diseases, including urinary stones; the first presentation to the urologist with AOP; the level of the bladder bacteriuria before the drainage of the obstructed kidney ≥103 CFU/ml. Bladder urine samples were collected for bacteriological examination by catheterization. At one, 3 and 6 months after completion of the treatment of AOP, the patients underwent a general clinical examination, and midstream specimens of urine were collected from the patients for bacteriological analysis to control leukocyturia and bacteriuria. Results. Eradication of causative uropathogens from urine occurred within 6 months in 96.1% of patients, and at that point, leukocyturia persisted in 23.5% of the patients. The decrease in detecting uropathogens in the urine was accompanied by an increase in the frequency of the presence in the urine of other aerobes and anaerobes, i.e., no sterile urine cultures were obtained from any patient. The rates of eradication of uropathogens were associated with the patients’ age, the duration of the pre-hospital stage of AOP, and the complicated course of AOP.

Full Text

Restricted Access

About the authors

Yu. L Naboka

RostSMU of Minzdrav of Russia

Email: nagu22@mail.ru
Dr.Med.Sci., Prof., Head of the Department of Microbiology and Virology №1

M. I Kogan

RostSMU of Minzdrav of Russia

Email: dept_kogan@mail.ru
the Honored Scientist of Russia, Dr.Med.Sci., Prof., Head of the Department of Urology and Human Reproductive Health with the Course of Pediatric Urology-Andrology, Faculty of AT and PRS

I. A Gudima

RostSMU of Minzdrav of Russia

Email: nagu22@mail.ru
Ph.D., Associate Prof. at the Department of Microbiology and Virology №1

E. V Mitusova

RostSMU of Minzdrav of Russia

Email: mitus21@mail.ru
Teaching Assistant at the Department of Microbiology and Virology №1

S. K Bedzhanyan

RostSMU of Minzdrav of Russia

Email: sarik2802@yandex.ru
Ph.D. Student at the Department of Urology and Human Reproductive Health with the Course of Pediatric Urology-Andrology, Faculty of AT and PRS

M. L Chernitskaya

RostSMU of Minzdrav of Russia

Email: nagu22@mail.ru
Ph.D., Associate Prof. at the Department of Microbiology and Virology №1

References

  1. Mazzulli T. Diagnosis and management of simple and complicated urinary tract infections (UTIs). Can. J. Urol. 2012;19(1):42-48.
  2. Colgan R., Williams M., Johnson J.R. Diagnosis and treatment of acute pyelonephritis in women. Am. Fam. Physician. 2011;84(5):519-526.
  3. Shields J., Maxwell A.P. Acute pyelonephritis can have serious complications. Practitioner. 2010;254(1728):19-21.
  4. Drai J. Management of acute pyelonephritis. J. Dr Prog. Urol. 2012;22(14):871-875.
  5. Wang A., Nizran P., Malone M.A., Riley T. Urinary Tract Infections. Primary Care: Clinics in Office Practice. 2013;40(3):687-706. doi: 10.1016/j.pop.2013.06.005.
  6. Sobel J.D., Kaye D. Urinary tract infections. Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. 8th ed. Philadelphia. 2015;886-913.
  7. Fasugba O., Gardner A., Mitchell B.G., Mnatzaganian G. Ciprofloxacin resistance in community-and hospital-acquired Escherichia coli urinary tract infec-tions: a systematic review and meta-analysis of observational studies. BMC Infect. Dis. 2015;15:545. doi: 10.1186/s12879-015-1282-4.
  8. Hudepohl N.J., Cuncha C.B., Mermel L.A. Antibiotic prescribing for urinary tract infections in the emergency department based on local antibiotic resistance patterns: implications for antimicrobial stewardship. Infect. Control. Hosp. Epidemiol. 2016;37:359-60. Doi: 10.1017/ ice.2015.283.
  9. Naboka J.L., Kogan M.I., Gudima I.A., Mitusova E.V. Microbiota bladder and pelvis urine in complicated infections of the upper urinary tract. Eur. Urol., supplements. 2015;14:e259-e259a.
  10. Mariappan P., Smith, G., Bariol S.V., Moussa S.A., Tolley D.A. Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J. Urol. 2005;173(5):1610-1614.
  11. Коган М.И., Набока Ю.Л., Ибишев Х.С., Газаев З.И., Черницкая М.Л., Гудима И.А., Моргун П.П., Левченко В.В., Митусова Е.В. Этиологическая структура острого обструктивного пиелонефрита и эффективность терапии. Стат. и тез. докл. II Конгр. урологов Сибири с междунар. участием. Томск. 2013;101-103
  12. Takhar S.S., Moran G.J. Diagnosis and management of urinary tract infection in the emergency department and outpatient settings. Infect. Dis. Clin. North. Am. 2014;28(1):33-48. doi: 10.1016/j.idc.2013.10.003.
  13. Wein A.J., Kavoussi L.R., Novick A.C. et al. Campbell-Walsh Urology. Philadelphia. 2012.
  14. St Lezin M., Hofmann R., Stoller M.L. Pyonephrosis: diagnosis and treatment. Br. J. Urol. 1992;70:360-63. doi: 10.1111/j.1464-410X.1992. tb15788.x.
  15. Chen Y., Nitzan O., Saliba W. Are blood cultures necessary in the management of women with complicated pyelonephritis? J. Infect. 2006;53(4):235-240.
  16. Ramakrishnan K., Scheid D.C. Diagnosis and management of acute pyelonephritis in adults. Am. Fam. Physician. 2005;71(5):933-942.
  17. Lee D.-G., Jeon S.H., Lee C.-H., Lee S.-J., Kim J. II, Chang S.-G. Acute pyelonephritis: clinical characteristics and the role of the surgical treatment. J. Korean Med. Sci. 2009;24(2):296-301. Doi: 10.3346/ jkms.2009.24.2.296.
  18. Бешлиев Д.А., Ходырева Л.А. Диагностика и лечение острого пиелонефрита. Трудный пациент. 2007;5(12-13):5-8
  19. Неймарк А.И., Гаткин М.Я., Использование криопреципитата в комплексном лечении острого гнойного пиелонефрита. Урология. 2005;4:42-48
  20. Белобородов, В.Б. Пиелонефрит в свете европейских рекомендаций по антибактериальной терапии уроинфекций. Consilium medicum. 2008;10(4):82-88
  21. Коган М.И., Набока Ю.Л., Гудима И.А., Митусова Е.В. Ближайшие и отдаленные результаты двух вариантов антибиотикотерапии осложненной инфекции верхних мочевых путей. Урологические ведомости. 2015;5(1):101-102
  22. Park D.W., Peck K.R., Chung M.H., Lee J.S., Park Y.S., Kim H.Y., Lee M.S., Kim J.Y., Yeom J.S., Kim M.J. Comparison of ertapenem and ceftriaxone therapy for acute pyelonephritis and other complicated urinary tract infections in Korean adults: a randomized, double-blind, multicenter trial. J. Korean Med. Sci. 2012;27(5):476-483. Doi: 10.3346/ jkms.2012.27.5.476.
  23. Sanchez M. Collvinent B., Miro O., Horcajada J.P., Moreno A., Marco F., Mensa J., Millá J. Short-term effectiveness of ceftriaxone single dose in the initial treatment of acute uncomplicated pyelonephritis in women. A randomised controlled trial. Emerg. Med. J. 2002;19(1):19-22.
  24. Bleidorn J., Hummers-Pradier E., Schmiemann G., Wiese B., Gágyor I. Recurrent urinary tract infections and complications after symptomatic versus antibiotic treatment: follow-up of a randomised controlled trial. Ger. Med. Sci. 2016;14:Doc01. eCollection 2016. doi: 10.3205/000228.
  25. Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infectious disease clinics of North America. 2014;28(1):1-13. doi: 10.1016/j.idc.2013.09.003.
  26. Коган М.И., Пасечник Д.Г., Набока Ю.Л., Ибишев Х.С., Газаев З.И., Гудима И.А. Могут ли неклостридиально-анаэробные бактерии вызывать острый пиелонефрит? (экспериментальное исследование). Урология. 2012;2:8-13

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies